Skip to main content

Table 2 Practitioner and practice response to the COVID-19 pandemic (n = 2050)

From: The impact and public health response of chiropractors to the COVID-19 pandemic: a survey across four continents

 

Overall n (% yes)

Australia n (% yes)

Canada n (% yes)

Denmark n (% yes)

Hong Kong n (% yes)

UK n (% yes)

USA n (% yes)

Others n (% yes)

Changes within practice setting in response to the COVID-19 outbreak

Increased disinfecting of treatment table/equipment*

1942 (94.7%)

270 (96.8%)

704 (97.2%)

131 (85.6%)

61 (88.4%)

447 (96.1%)

301 (91.5%)

28 (90.3%)

Increased disinfecting of high contact areas*

1934 (94.3%)

264 (94.6%)

711 (98.2%)

146 (95.4%)

57 (82.6%)

436 (92.8%)

293 (89.1%)

27 (87.1%)

Increased disinfecting/cleaning of my hands*

1920 (93.7%)

265 (95.0%)

704 (97.2%)

134 (87.6%)

69 (100%)

435 (93.5%)

289 (87.8%)

24 (77.4%)

Providing patient hand sanitiser*

1909 (93.1%)

269 (96.4%)

724 (95.0%)

144 (94.1%)

62 (89.9%)

449 (96.6%)

266 (80.9%)

31 (100%)

Social distance patient seating*

1828 (89.2%)

246 (88.2%)

690 (95.3%)

142 (92.8%)

40 (58.0%)

405 (87.1%)

277 (84.2%)

28 (90.3%)

Change spacing patient bookings*

1629 (79.5%)

186 (66.7%)

663 (91.6%)

98 (64.1%)

23 (33.3%)

416 (89.5%)

223 (67.8%)

20 (64.5%)

Protective screen added to reception desk*

1202 (58.6%)

81 (29.0%)

549 (75.8%)

117 (76.5%)

36 (52.2%)

270 (58.1%)

134 (40.7%)

15 (48.4%)

Care restricted to urgent/emergency cases*

805 (39.3%)

67 (24.0%)

370 (46.0%)

75 (49.0%)

9 (13.0%)

202 (43.4%)

73 (22.2%)

9 (29.0%)

Patient care stopped*

764 (37.3%)

230 (17.6%)

351 (48.5%)

34 (22.2%)

1 (1.4%)

246 (52.9%)

71 (21.6%)

12 (38.7%)

None of the above

10 (0.5%)

0 (0.0%)

3 (0.4%)

0 (0.0%)

0 (0.0%)

2 (0.4%)

4 (1.2%)

1 (3.1%)

Government/regulator advice on practitioner use of personal protective equipment (PPE) in response to COVID-19 (n = 2058)

Wearing cloth/standard surgical mask*

1755 (85.3%)

188 (67.4%)

670 (92.2%)

134 (87.6%)

65 (94.2%)

407 (87.2%)

289 (80.7%)

23 (74.2%)

Wearing face and/or eye shielding*

969 (47.1%)

23 (8.2%)

82 (11.3%)

9 (5.9%)

31 (44.9%)

82 (17.6%)

66 (19.9%)

8 (25.8%)

Wearing new disposable gloves during treatment*

723 (35.1%)

44 (15.8%)

90 (12.4%)

3 (2.0%)

50 (72.5%)

440 (94.2%)

88 (26.5%)

8 (25.8%)

Wearing protective garments/clothing*

673 (32.7%)

15 (5.4%)

180 (24.8%)

0 (0.0%)

10 (14.5%)

427 (91.4%)

39 (11.7%)

2 (6.5%)

Wearing N95 respirator/mask*

301 (14.6%)

23 (8.2%)

82 (11.3%)

9 (5.9%)

31 (44.9%)

82 (17.6%)

66 (19.9%)

8 (25.8%)

None of the above were advised*

86 (4.1%)

46 (16.5%)

15 (2.1%)

2 (2.9%)

2 (2.9%)

5 (1.1%)

12 (14.1%)

23 (74.2%)

Not sure what was advised*

61 (3.0%)

23 (13.6%)

8 (1.1%)

1 (0.7%)

1 (1.4%)

8 (1.7%)

19 (5.7%)

1 (3.2%)

Implementation of advised use of personal protective equipment (PPE) for chiropractors (n = 2025)*

Yes, all that were advised (when available)

1611 (84.8%)

150 (58.8%)

603 (83.3%)

138 (91.4%)

64 (97.0%)

405 (86.9%)

233 (70.2%)

18 (58.1%)

Yes, some of what was advised

253 (12.9%)

40 (15.8%)

93 (12.8%)

10 (6.6%)

1 (1.5%)

48 (10.3%)

55 (16.6%)

6 (19.4%)

Never or rarely

161 (2.3%)

65 (25.5%)

28 (3.9%)

3 (2.0%)

1 (1.5%)

13 (2.8%)

44 (13.3%)

7 (22.6%)

Government/regulator advice on patient use of personal protective equipment (PPE) in response to COVID-19 (n = 2057)

Wearing cloth/standard surgical mask*

1697 (82.5%)

160 (57.8%)

649 (89.3%)

135 (88.2%)

66 (97.1%)

380 (81.4%)

286 (85.9%)

21 (65.6%)

Wearing face and/or eye shielding*

189 (9.2%)

11 (4.0%)

35 (4.8%)

34 (22.2%)

42 (60.9%)

37 (7.9%)

28 (8.4%)

2 (6.3%)

Wearing an N95 respirator/mask*

119 (5.8%)

10 (3.6%)

23 (3.2%)

6 (3.9%)

31 (44.9%)

18 (3.9%)

29 (8.7%)

2 (6.3%)

Wearing new disposable gloves during treatment *

114 (5.5%)

2 (0.7%)

14 (1.9%)

0 (0.0%)

41 (59.4%)

42 (9.0%)

11 (3.3%)

4 (3.5%)

Wearing protective garments/clothing

61 (3.0%)

0.0 (0.0%)

17 (2.3%)

0 (0.0%)

3 (4.3%)

38 (8.1%)

3 (0.9%)

0 (0.0%)

None of the above were advised*

209 (10.2%)

76 (27.3%)

54 (7.4%)

7 (4.6%)

2 (2.9%)

48 (10.3%)

14 (4.2%)

8 (25.0%)

Not sure what was advised*

94 (4.6%)

32 (11.5%)

12 (1.7%)

1 (0.7%)

1 (1.4%)

23 (4.9%)

24 (7.2%)

1 (3.1%)

Implementation of advised use of personal protective equipment (PPE) for patients (n = 2016)*

Yes, all that were advised (when available)

1524 (75.6%)

128 (52.2%)

597 (82.2%)

138 (91.4%)

64 (95.5%)

350 (75.6%)

230 (69.1%)

17 (54.8%)

Yes, some of what was advised

165 (8.2%)

24 (9.8%)

51(7.0%)

5 (3.3%)

2 (3.0%)

32 (19.4%)

47 (14.1%)

17 (54.8%)

Never or rarely

327 (16.2%)

93 (38.1%)

78 (10.7%)

8 (5.3%)

1 (0.3%)

82 (24.8%)

56 (16.8%)

10 (32.3%)

Approach to care recommended for patients presenting with COVID-19 or similar flu-like symptoms (n = 2056)*

Avoid treatment until after testing -ve or after quarantine for at least 2 weeks if + ve

1698 (82.6%)

239 (86.3%)

612 (84.4%)

111 (72.5%)

60 (87.0%)

414 (88.7%)

238 (71.5%)

24 (75.0%)

Advise to avoid treatment until after their symptoms passed

237 (11.5%)

20 (7.2%)

87 (12.0%)

37 (24.2%)

3 (4.3%)

40 (8.6%)

45 (13.5%)

5 (15.6%)

Provide treatment using additional protective measures

90 (4.4%)

16 (5.8%)

19 (2.6%)

4 (2.6%)

4 (5.8%)

8 (1.7%)

39 (11.4%)

1 (3.1%)

Provide treatment without additional protective measures

19 (0.9%)

1 (0.4%)

4 (0.6%)

0 (0.0%)

2 (2.9%)

4 (0.9%)

7 (2.1%)

1 (3.1%)

Not sure what to do

12 (0.6%)

1 (0.4%)

3 (0.4%)

1 (0.7%)

0 (0.0%)

1 (0.2%)

5 (1.5%)

1 (3.1%)

Use of teleconferencing/telehealth before the COVID-19 outbreak began (n = 2051)*

Yes

107 (5.2%)

12 (4.3%)

20 (2.8%)

9 (5.9%)

2 (1.9%)

35 (7.5%)

28 (8.4%)

1 (3.2%)

Use of teleconferencing/telehealth since the COVID-19 outbreak began (n = 1947)*

Yes

515 (26.5%)

33 (12.4%)

176 (25.0%)

24 (16.7%)

1 (1.5%)

196 (45.4%)

76 (25.0%)

9 (29.0%)

Percentage of patient consultations provided through teleconferencing during the peak of the COVID-19 outbreak (n = 621)*

More than 75%

157 (25.2%)

3 (6.7%)

39 (20.0%)

4 (12.1%)

1 (33.3%)

35 (7.5%)

28 (8.4%)

2 (20.0%)

Between 50–75%

19 (2.9%)

1 (5.6%)

5 (2.8%)

0 (0.0%)

0 (0.0%)

7 (3.0%)

5 (4.8%)

0 (0.0%)

Between 25–50%

29 (4.7%)

2 (4.4%)

7 (3.6%)

2 (6.1%)

1 (33.3%)

8 (3.5%)

9 (8.7%)

0 (0.0%)

Between 1–25%

263 (42.4%)

34 (75.6%)

105 (53.8%)

23 (69.7%)

1 (33.3%)

52 (22.5%)

45 (43.3%)

3 (30.0%)

Not in practise during peak

154 (24.8%)

5 (11.1%)

39 (20.0%)

4 (12.1%)

0 (0.0%)

84 (36.4%)

17 (16.3%)

5 (50.0%)

A lack of third-party financial funding as barrier to the use of teleconferencing during COVID-19 (n = 2042)*

No

1154 (56.6%)

160 (57.8%)

468 (65.3%)

129 (84.9%)

52 (75.4%)

156 (33.5%)

174 (52.7%)

15 (46.9%)

Yes

328 (16.1%)

56 (20.2%)

113 (15.8%)

14 (9.2%)

4 (5.8%)

48 (10.3%)

90 (27.4%)

3 (9.4%)

Not relevant (all care is fully patient funded)

560 (20.6%)

61 (10.9%)

136 (19.0%)

9 (5.9%)

13 (18.8%)

261 (56.1%)

66 (20.0%)

14 (43.3%)

Independent guidelines needed for public health procedures for manual therapy practitioners (n = 2053)*

No, same guidelines for all healthcare practitioners

936 (45.6%)

103 (37.1%)

332 (45.8%)

88 (58.3%)

51 (75.0%)

176 (37.7%)

175 (52.7%)

11 (34.4%)

Yes

848 (41.3%)

138 (49.6%)

276 (38.1%)

51 (33.8%)

15 (22.1%)

240 (51.4%)

113 (34.0%)

15 (46.9%)

Unsure

269 (13.1%)

37 (13.3%)

117 (16.1%)

12 (7.9%)

2 (2.9%)

51 (10.9%)

44 (13.3%)

6 (18.8%)

  1. Some items with missing data ranging from 1 to 11 respondents, *P < 0.001